Dario Sangiolo

22PUBLICATIONS
130CO-AUTHORS
Cellular immunologyMolecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jan 10, 2026
ChronoimmunoTOX: A Single-Institution Retrospective Study on How the Time of Administration Impacts Immune Checkpoint Inhibitor Efficacy and Toxicity in Melanoma.

Alessandro Nepote, Gilles Burghgraeve, Martino Pedrani

|Dec 23, 2025
Correction: Development and activity of canine B7-H3-CAR.CIK lymphocytes against sarcomas: preclinical evidence and perspectives for human clinical translation.

Raffaella De Maria, Chiara Donini, Sonia Capellero

|Sep 13, 2025
Development and activity of canine B7-H3-CAR.CIK lymphocytes against sarcomas: preclinical evidence and perspectives for human clinical translation.

Raffaella De Maria, Chiara Donini, Sonia Capellero

|Jul 12, 2025
Shifting Shapes: The Endothelial-to-Mesenchymal Transition as a Driver for Cancer Progression.

Lucia Giordanengo, Alessia Proment, Virginia Botta

|Nov 02, 2024
Three-dimensional dynamics of mesothelin-targeted CAR.CIK lymphocytes against ovarian cancer peritoneal carcinomatosis.

Federica Galvagno, Valeria Leuci, Annamaria Massa

|Sep 16, 2024
Predictive and Dynamic Signature for Antiangiogenics in Combination with a PD1 Inhibitor in Soft-Tissue Sarcoma: Correlative Studies Linked to the IMMUNOSARC Trial.

David S Moura, Jesus M Lopez-Marti, Iva Benesova

Pageof 4

Frequent Collaborators

8 joint publications

Valeria Leuci

7 joint publications

Chiara Donini

6 joint publications

Elisa Vigna

6 joint publications

Giovanni Grignani